October 7, 2012

America’s Healthcare Crisis–Part V–FDA Complicit in Crimes

VIII. FDA is the pivotal regulatory gatekeeper entrusted with: “protecting the public health by assuring the safety

Read More
America’s Healthcare Crisis–Part V–FDA Complicit in Crimes

April 16, 2010

Specific Anticonvulsants Increase Suicide Risk

The Harvard study,  published in the Journal of the American Medical Association, evaluated 827 suicidal acts (801

Read More
Specific Anticonvulsants Increase Suicide Risk

December 2, 2009

BIG PHARMA’s CRIME SPREE

BIG PHARMA’S CRIME SPREE is a riveting report by David Evans in the current issue of Bloomberg

Read More
BIG PHARMA’s CRIME SPREE

February 24, 2009

Drug-induced Risk of Cardiac Death: NYS Advisory_APA Guidance

The legitimacy of psychiatry’s clinical practices is unraveling as a copious body of evidence—documented in state /

Read More
Drug-induced Risk of Cardiac Death: NYS Advisory_APA Guidance

February 6, 2007

Evidence: Why you should never trust new wonder drugs

The tobacco industry denied the direct evidence by misapplying government population statistics showing improved health and longevity

Read More
Evidence: Why you should never trust new wonder drugs

January 22, 2007

Role of Litigation in Defining Drug Risks_JAMA / BMJ

Below are excerpts from two timely articles that offer persuasive arguments backed by evidence demonstrating that litigation

Read More
Role of Litigation in Defining Drug Risks_JAMA / BMJ

December 1, 2006

New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost

The second phase of the government study, Clinical Antipsychotic Trials inIntervention Effectiveness (CATIE), was released and the

Read More
New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost

November 23, 2006

Dangerous Deception: Hiding the Evidence of Adverse Drug Effects_NEJM

The drug industry's undue influence–on the FDA and its advisory committees that are made up mostly of

Read More
Dangerous Deception: Hiding the Evidence of Adverse Drug Effects_NEJM

October 26, 2006

FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post

FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post Thu, 18 Nov 2004

Read More
FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post

October 26, 2006

Columbia Journalism Review–The Complicity of the Media in Drug Marketing

Columbia Journalism Review–The Complicity of the Media in Drug Marketing Wed, 27 Jul 2005 An excellent article

Read More
Columbia Journalism Review–The Complicity of the Media in Drug Marketing

October 26, 2006

Doctors On the Take-Engaging in Vairous Dubious Activities for Cash / Stock Options

Doctors On the Take-Engaging in Vairous Dubious Activities for Cash / Stock Options Tue, 16 Aug 2005

Read More
Doctors On the Take-Engaging in Vairous Dubious Activities for Cash / Stock Options

October 26, 2006

At FDA, Changes In Name Only–Agency Puts Business interests Above Safety

At FDA, Changes In Name Only–Agency Puts Business interests Above Safety Fri, 30 Sep 2005 The sudden

Read More
At FDA, Changes In Name Only–Agency Puts Business interests Above Safety

October 26, 2006

FDA Standards – Good Enough for Government Work?

FDA Standards – Good Enough for Government Work? Fri, 23 Sep 2005 An essay in The New

Read More
FDA Standards – Good Enough for Government Work?

October 26, 2006

Safety of American Drugs Questioned – Assoc Press

Safety of American Drugs Questioned – Assoc Press Thu, 2 Dec 2004 In his CNN news program

Read More
Safety of American Drugs Questioned – Assoc Press